Molecular evolution of proadrenomedullin N-terminal 20 peptide (PAMP): Evidence for gene co-option

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3457-3461

  Martínez, Alfredo ^a   Bengoechea, José Antonio ^b   Cuttitta, Frank ^c  

^a INSTITUTO CAJAL   (Spain)

^b Fundacion Caubet CIMERA   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; PROADRENOMEDULLIN;

AMIDATION; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; CONFORMATIONAL TRANSITION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN VERSUS ANIMAL COMPARISON; MOLECULAR EVOLUTION; NATURAL SELECTION; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SPECIES COMPARISON; STRUCTURAL HOMOLOGY;

1-NAPHTHYLAMINE; ADRENOMEDULLIN; ANIMALS; CHICKENS; EVOLUTION, MOLECULAR; HUMANS; MICE; MODELS, GENETIC; NEOVASCULARIZATION, PATHOLOGIC; OPEN READING FRAMES; PEPTIDES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 33745149395     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0105     Document Type: Article

References (46)

1. Lopez J, Martinez A 2002 Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 221:1-92
2. Montuenga LM, Martinez A, Miller MJ, Unsworth EJ, Cuttitta F 1997 Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology 138:440-451
3. Julian M, Cacho M, Garcia MA, Martin-Santamaria S, de Pascual-Teresa B, Ramos A, Martinez A, Cuttitta F 2005 Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur J Med Chem 40:737-750
4. Allaker RP, Zihni C, Kapas S 1999 An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 23:289-293
5. 2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res 64:6489-6494
6. Kitamura K, Kangawa K, Eto T 2002 Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 57:3-13
7. Kanazawa H, Kawaguchi T, Fujii T, Kudoh S, Hirata K, Kurihara N, Takeda T 1995 Comparison of bronchodilator responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide. Life Sci 57:L241-L245
8. Shimosawa T, Ando K, Fujita T 1997 A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms. Hypertension 30:1009-1014
9. Belloni AS, Albertin G, Forneris ML, Nussdorfer GG 2001 Proadrenomedullin-derived peptides as autocrine-paracrine regulators of cell growth. Histol Histopathol 16:1263-1274
10. Samson WK, Murphy TC, Resch ZT 1998 Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel. Endocrine 9:269-272
11. Andreis PG, Tortorella C, Mazzocchi G, Nussdorfer GG 1998 Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect. J Clin Endocrinol Metab 83:253-257
12. 2+-dependent, agonist-stimulated secretion of human adrenal glands. Hypertension 33:1185-1189
13. Fernandez dA, I, Lostao MP, Martinez A, Berjon A, Barber A 2005 Effect of adrenomedullin and proadrenomedullin N-terminal 20 peptide on sugar transport in the rat intestine. Regul Pept 129:147-154
14. Zudaire E, Cuesta N, Martinez A, Cuttitta F 2005 Characterization of adrenomedullin in birds. Gen Comp Endocrinol 143:10-20
15. Ogoshi M, Inoue K, Takei Y 2003 Identification of a novel adrenomedullin gene family in teleost fish. Biochem Biophys Res Commun 311:1072-1077
16. Conlon JM, Larhammar D 2005 The evolution of neuroendocrine peptides. Gen Comp Endocrinol 142:53-59
17. Zudaire E, Martinez A, Ozbun LL, Cuttitta F 2004 Characterization of adrenomedullin in non-human primates. Biochem Biophys Res Commun 321:859-869
18. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson WG, Kleinman HK, Cuttitta F 2002 The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 94:1226-1237
19. Notari L, Miller A, Martinez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP 2005 Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46:2736-2747
20. Zudaire E, Martinez A, Garayoa M, Pio R, Kaur G, Woolhiser MR, Metcalfe DD, Hook WA, Siraganian RP, Guise TA, Chirgwin JM, Cuttitta F 2006 Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol 168:280-291
21. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P 1991 Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 137:167-173
22. Bengoechea JA, Diaz R, Moriyon I 1996 Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect Immun 64:4891-4899
23. Loh B, Grant C, Hancock RE 1984 Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26:546-551
24. Vaara M 1992 Agents that increase the permeability of the outer membrane. Microbiol Rev 56:395-411
25. Allaker RP, Grosvenor PW, McAnerney DC, Sheehan BE, Srikanta BH, Pell K, Kapas S 2006 Mechanisms of adrenomedullin antimicrobial action. Peptides 27:661-666
26. Palmer DR, Garrett JB, Sharma V, Meganathan R, Babbitt PC, Gerlt JA 1999 Unexpected divergence of enzyme function and sequence: "N-acylamino acid racemase" is o-succinylbenzoate synthase. Biochemistry 38:4252-4258
27. Carginale V, Trinchella F, Capasso C, Scudiero R, Riggio M, Parisi E 2004 Adaptive evolution and functional divergence of pepsin gene family. Gene 333:81-90
28. Grishin NV 2000 Two tricks in one bundle: helix-turn-helix gains enzymatic activity. Nucleic Acids Res 28:2229-2233
29. Thoden JB, Taylor Ringia EA, Garrett JB, Gerlt JA, Holden HM, Rayment I 2004 Evolution of enzymatic activity in the enolase superfamily: structural studies of the promiscuous o-succinylbenzoate synthase from Amycolatopsis. Biochemistry 43:5716-5727
30. Singer SS, Mannel DN, Hehlgans T, Brosius J, Schmitz J 2004 From "junk" to gene: curriculum vitae of a primate receptor isoform gene. J Mol Biol 341:883-886
31. Bielawski JP, Yang Z 2004 A maximum likelihood method for detecting functional divergence at individual codon sites, with application to gene family evolution. J Mol Evol 59:121-132
32. Seo TK, Kishino H, Thorne JL 2004 Estimating absolute rates of synonymous and nonsynonymous nucleotide substitution in order to characterize natural selection and date species divergences. Mol Biol Evol 21:1201-1213
33. Lynn DJ, Lloyd AT, Fares MA, O'Farrelly C 2004 Evidence of positively selected sites in mammalian α-defensins. Mol Biol Evol 21:819-827
34. Zhang J, Rosenberg HF 2002 Diversifying selection of the tumor-growth promoter angiogenin in primate evolution. Mol Biol Evol 19:438-445
35. Tennessen JA 2005 Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection. J Evol Biol 18:1387-1394
36. Walker JR, Altman RK, Warren JW, Altman E 2003 Using protein-based motifs to stabilize peptides. J Pept Res 62:214-226
37. Duclohier H 2002 How do channel- and pore-forming helical peptides interact with lipid membranes and how does this account for their antimicrobial activity? Mini Rev Med Chem 2:331-342
38. Yeaman MR, Yount NY 2003 Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55
39. 1H NMR spectroscopy. J Biomol Struct Dyn 18:595-606
40. Lucyk S, Taha H, Yamamoto H, Miskolzie M, Kotovych G 2006 NMR conformational analysis of proadrenomedullin N-terminal 20 peptide, a proangiogenic factor involved in tumor growth. Biopolymers 81:295-308
41. Czyzyk TA, Ning Y, Hsu MS, Peng B, Mains RE, Eipper BA, Pintar JE 2005 Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev Biol 287:301-313
42. Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, Cen P 2006 Recent advances in the research and development of human defensins. Peptides 27:931-940
43. Martinez A, Elsasser TH, Muro-Cacho C, Moody TW, Miller MJ, Macri CJ, Cuttitta F 1997 Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138:5597-5604
44. Litman GW, Cannon JP, Dishaw LJ 2005 Reconstructing immune phylogeny: new perspectives. Nat Rev Immunol 5:866-879
45. Ausubel FM 2005 Are innate immune signaling pathways in plants and animals conserved? Nat Immunol 6:973-979
46. Hornef MW, Normark S, Henriques-Normark B, Rhen M 2005 Bacterial evasion of innate defense at epithelial linings. Chem Immunol Allergy 86:72-98